portal
  Home About us Reports Charts News Custom Company Scan  
Report Charts News
*
Title Content
Economy&Goods
  Economy
  ConsumerGoods
  Food&Beverage
  Agriculture
Life Sciences
  Biotechnology
  Medical
  Pharmaceutical
Manufacturing
  Automotive
  Chemical
  Energy
  Machinery
  Material
  Metals & Minerals
Public Sector
  Environment
  Finance Service
  Infrastructure
  Logistics
  Real Estate
  Retailing
  Tourism
  Training
Technology And Media
  Electronics
  Internet
  Hardware
  Media
  Software
  Telecommunications

Tel: 0086-10-82600828
Fax: 0086-10-82601570
Email:


Tianjin Ringpu Bio-technology Co.,Ltd.(300119.SZ)

Profile
Registered Capital:
148.30(RMB MLN)
Employees:
1357
Email:
zqb@ringpu.com

WebSite:
http://www.ringpu.com
Tel:
022-24981953
Fax:
022-24981953
Revenue Breakdown (million RMB)
Industry2010H1200920082007
Veterinary drugs manufacturing158.98******
Total158.98******
Products2011H120102010H1200920082007
Veterinary Biologics************
Veterinary preparations************
Animal raw materials************
Total************
Area2011H120102010H1200920082007
Northeast region25.19**********
China North55.21**********
Shandong area40.70**********
Henan area15.26**********
East China area33.25**********
Central China area26.55**********
Southwest District28.49**********
Other area21.11**********
Foreign area21.80**********
Total267.58**********
Introduction from Company WebSite

TIANJIN RINGPU BIO-TECHNOLOGY CO.,LTD. is principally engaged in the research, development, production and distribution of biological products and preparations for veterinary use. The Company's biological products for veterinary use include vaccine for poultry and vaccine for livestock, mainly used in the prevention of chicken and pigs. The Company's preparations for veterinary use include powder, oral liquid, injections, granules and tablets, mainly used in the prevention and treatment of the diseases of poultry and livestock, as well as feed additive, mainly used in the regulation of physiological functions of animals, among others. During the year ended December 31, 2009, the Company obtained approximately 75% and 25% of its total revenue from biological products for veterinary use and preparations for veterinary use, respectively. 

2005-2021 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1